Estimated glomerular filtration rate progression in UK primary care patients with type 2 diabetes and diabetic kidney disease: a retrospective cohort study.

Cid Ruzafa, J; Paczkowski, R; Boye, K S; Di Tanna, G L; Sheetz, M J; Donaldson, R; Breyer, M D; Neasham, D; Voelker, J R

Cid Ruzafa, J; Paczkowski, R; Boye, K S; Di Tanna, G L; Sheetz, M J; Donaldson, R; Breyer, M D; Neasham, D; Voelker, J R.

Affiliation

Cid Ruzafa J; Evidera, London, UK.
Paczkowski R; Eli Lilly and Company, Indianapolis, IN, USA.
Boye KS; Eli Lilly and Company, Indianapolis, IN, USA.
Di Tanna GL; Evidera, London, UK.
Sheetz MJ; Eli Lilly and Company, Indianapolis, IN, USA.
Donaldson R; Evidera, London, UK.
Breyer MD; Eli Lilly and Company, Indianapolis, IN, USA.
Neasham D; Evidera, London, UK.
Voelker JR; Eli Lilly and Company, Indianapolis, IN, USA.

Int J Clin Pract ; 69(8): 871-82, 2015 Aug.

Article in En | MEDLINE | ID: mdl-26011029

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Diabetic Nephropathies / Glomerular Filtration Rate / Kidney Failure, Chronic Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Int J Clin Pract Journal subject: MEDICINA Year: 2015 Document type: Article Affiliation country: Country of publication:

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google